CARDURA TABLET 2 mg

Ülke: Singapur

Dil: İngilizce

Kaynak: HSA (Health Sciences Authority)

Aktif bileşen:

DOXAZOSIN MESYLATE 2.43MG EQV DOXAZOSIN

Mevcut itibaren:

VIATRIS PRIVATE LIMITED

ATC kodu:

C02CA04

Doz:

2 mg

Farmasötik formu:

TABLET

Kompozisyon:

DOXAZOSIN MESYLATE 2.43MG EQV DOXAZOSIN 2 mg

Uygulama yolu:

ORAL

Reçete türü:

Prescription Only

Tarafından üretildi:

Pfizer Manufacturing Deutschland GmbH

Yetkilendirme durumu:

ACTIVE

Yetkilendirme tarihi:

1990-08-16

Bilgilendirme broşürü

PFIZER
CARDURA
*
Doxazosin Mesylate
1.
NAME OF THE MEDICINAL PRODUCT
CARDURA
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Active ingredient: doxazosin
The tablets contain doxazosin mesylate salt equivalent to 1 mg, 2 mg
and 4 mg
doxazosin.
3.
PHARMACEUTICAL FORM
Tablets
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
_Hypertension_
Doxazosin is indicated for the treatment of hypertension and can be
used as the initial
agent to control blood pressure in the majority of patients. In
patients not adequately
controlled on a single antihypertensive agent, doxazosin may be used
in combination
with another agent, such as a thiazide diuretic, a beta-blocker, a
calcium antagonist or
an angiotensin-converting enzyme inhibitor.
_Benign Prostatic Hyperplasia_
Doxazosin is also indicated for the treatment of the urinary outflow
obstruction and
symptoms associated with benign prostatic hyperplasia (BPH). Doxazosin
may be
used in BPH patients who are either hypertensive or normotensive.
While the blood
pressure changes in normotensive patients with BPH are clinically
insignificant,
patients with hypertension and BPH have had both conditions
effectively treated with
doxazosin monotherapy.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Doxazosin may be administered either in the morning or in the evening.
_Hypertension_
The full dosage range of doxazosin is 1 mg to 16 mg daily. It is
recommended that
therapy be initiated at 1 mg once daily for 1 or 2 weeks to minimize
the potential for
postural hypotension and/or syncope (see section 4.4 SPECIAL WARNINGS
AND
PRECAUTIONS FOR USE). The dosage may then be increased to 2 mg once
daily for an
additional 1 or 2 weeks. If necessary, the daily dosage should then be
increased
gradually at similar intervals to 4 mg, 8 mg, and 16 mg, as determined
by patient
response, to achieve the desired reduction in blood pressure. The
usual dose is 2 mg to
4 mg once daily.
_Benign Prostatic Hyperplasia_
The recommended initial dosage of doxazosin is 1 mg once daily to
minimize the
potential for postural

Ürün özellikleri

CARDURA
®
Doxazosin Mesylate
1.
NAME OF THE MEDICINAL PRODUCT
CARDURA
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Active ingredient: doxazosin
The tablets contain doxazosin mesylate salt equivalent to 1 mg, 2 mg
and 4 mg
doxazosin.
3.
PHARMACEUTICAL FORM
Tablets
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
_Hypertension_
Doxazosin is indicated for the treatment of hypertension and can be
used as the initial
agent to control blood pressure in the majority of patients. In
patients not adequately
controlled on a single antihypertensive agent, doxazosin may be used
in combination
with another agent, such as a thiazide diuretic, a beta-blocker, a
calcium antagonist or
an angiotensin-converting enzyme inhibitor.
_Benign Prostatic Hyperplasia_
Doxazosin is also indicated for the treatment of the urinary outflow
obstruction and
symptoms associated with benign prostatic hyperplasia (BPH). Doxazosin
may be
used in BPH patients who are either hypertensive or normotensive.
While the blood
pressure changes in normotensive patients with BPH are clinically
insignificant,
patients with hypertension and BPH have had both conditions
effectively treated with
doxazosin monotherapy.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Doxazosin may be administered either in the morning or in the evening.
_Hypertension_
The full dosage range of doxazosin is 1 mg to 16 mg daily. It is
recommended that
therapy be initiated at 1 mg once daily for 1 or 2 weeks to minimize
the potential for
postural hypotension and/or syncope (see section
4.4 SPECIAL WARNINGS AND
PRECAUTIONS FOR USE
). The dosage may then be increased to 2 mg once daily for an
additional 1 or 2 weeks. If necessary, the daily dosage should then be
increased
gradually at similar intervals to 4 mg, 8 mg, and 16 mg, as determined
by patient
response, to achieve the desired reduction in blood pressure. The
usual dose is 2 mg to
4 mg once daily.
_Benign Prostatic Hyperplasia_
The recommended initial dosage of doxazosin is 1 mg once daily to
minimize the
potential for postural hypot